Viral
Differential expression of cellular microRNAs in HPV-11 transfected cells. An analysis by three different array platforms and qRT-PCR.
Dreher A, Rossing M, Kaczkowski B, Nielsen FC, Norrild B.
Biochem Biophys Res Commun. 2010 Dec 17;403(3-4):357-62.
Transcriptome and proteome profiling of host responses to Marek's disease virus in chickens.
Haq K, Brisbin JT, Thanthrige-Don N, Heidari M, Sharif S.
Vet Immunol Immunopathol. 2010 Dec 15;138(4):292-302.
Functional microRNA generated from a cytoplasmic RNA virus.
Rouha H, Thurner C, Mandl CW.
Nucleic Acids Res. 2010 Dec 1;38(22):8328-37.
Viral oncogenes, noncoding RNAs, and RNA splicing in human tumor viruses.
Zheng ZM.
Int J Biol Sci. 2010 Dec 1;6(7):730-55.
[Epstein-Barr virus (EBV) and Kaposi's sarcoma-associated herpesvirus (KSHV, HHV-8)].
Katano H.
Uirusu. 2010 Dec;60(2):237-45.
Bioinformatic analysis of the neutrality of RNA secondary structure elements across genotypes reveals evidence for direct evolution of
genetic robustness in HCV.
Churkin A, Cohen M, Shemer-Avni Y, Barash D.
J Bioinform Comput Biol. 2010 Dec;8(6):1013-26.
Triplex-forming MicroRNAs form stable complexes with HIV-1 provirus and inhibit its replication.
Kanak M, Alseiari M, Balasubramanian P, Addanki K, Aggarwal M, Noorali S, Kalsum A, Mahalingam K, Pace G, Panasik N, Bagasra O.
Appl Immunohistochem Mol Morphol. 2010 Dec;18(6):532-45.
Correlation between microRNA expression levels and clinical parameters associated with chronic hepatitis C viral infection in humans.
Marquez RT, Bandyopadhyay S, Wendlandt EB, Keck K, Hoffer BA, Icardi MS, Christensen RN, Schmidt WN, McCaffrey AP.
Lab Invest. 2010 Dec;90(12):1727-36.
Regulation of tumor necrosis factor-like weak inducer of apoptosis receptor protein (TWEAKR) expression by Kaposi's sarcoma-
associated herpesvirus microRNA prevents TWEAK-induced apoptosis and inflammatory cytokine expression.
Abend JR, Uldrick T, Ziegelbauer JM.
J Virol. 2010 Dec;84(23):12139-51.
Differential expression of interferon-induced microRNAs in patients with chronic hepatitis C virus infection treated with pegylated interferon
alpha.
Scagnolari C, Zingariello P, Vecchiet J, Selvaggi C, Racciatti D, Taliani G, Riva E, Pizzigallo E, Antonelli G.
Virol J. 2010 Nov 12;7:311.
Discovering microRNAs from Bombyx mori nucleopolyhedrosis virus.
Singh J, Singh CP, Bhavani A, Nagaraju J.
Virology. 2010 Nov 10;407(1):120-8.
Changes to euchromatin on LAT and ICP4 following reactivation are more prevalent in an efficiently reactivating strain of HSV-1.
Creech CC, Neumann DM.
PLoS One. 2010 Nov 4;5(11):e15416.
Autoantibodies to a miRNA-binding protein Argonaute2 (Su antigen) in patients with hepatitis C virus infection.
Vázquez-Del Mercado M, Sánchez-Orozco LV, Pauley BA, Chan JY, Chan EK, Panduro A, Maldonado González M, Jiménez-Luévanos
MA, Martín-Márquez BT, Palafox-Sánchez CA, Dávalos-Rodríguez IP, Salazar-Páramo M, González-López L, Gámez-Nava JI, Satoh M.
Clin Exp Rheumatol. 2010 Nov-Dec;28(6):842-8.
Parallel microRNA and mRNA expression profiling of (genotype 1b) human hepatoma cells expressing hepatitis C virus.
Steuerwald NM, Parsons JC, Bennett K, Bates TC, Bonkovsky HL.
Liver Int. 2010 Nov;30(10):1490-504.
Latency of herpes simplex virus type-1 in human geniculate and vestibular ganglia is associated with infiltration of CD8+ T cells.
Arbusow V, Derfuss T, Held K, Himmelein S, Strupp M, Gurkov R, Brandt T, Theil D.
J Med Virol. 2010 Nov;82(11):1917-20.
New insights into structure and replication of the hepatitis C virus and clinical implications.
Poenisch M, Bartenschlager R.
Semin Liver Dis. 2010 Nov;30(4):333-47.
Suppression of hepatitis B virus replication by microRNA-199a-3p and microRNA-210.
Zhang GL, Li YX, Zheng SQ, Liu M, Li X, Tang H.
Antiviral Res. 2010 Nov;88(2):169-75.
Marek's disease virus microRNA designated Mdv1-pre-miR-M4 targets both cellular and viral genes.
Muylkens B, Coupeau D, Dambrine G, Trapp S, Rasschaert D.
Arch Virol. 2010 Nov;155(11):1823-37.
Noncanonical cytoplasmic processing of viral microRNAs.
Shapiro JS, Varble A, Pham AM, Tenoever BR.
RNA. 2010 Nov;16(11):2068-74.
Andes virus regulation of cellular microRNAs contributes to hantavirus-induced endothelial cell permeability.
Pepini T, Gorbunova EE, Gavrilovskaya IN, Mackow JE, Mackow ER.
J Virol. 2010 Nov;84(22):11929-36.
Virally induced cellular microRNA miR-155 plays a key role in B-cell immortalization by Epstein-Barr virus.
Linnstaedt SD, Gottwein E, Skalsky RL, Luftig MA, Cullen BR.
J Virol. 2010 Nov;84(22):11670-8.
A p53-dependent promoter associated with polymorphic tandem repeats controls the expression of a viral transcript encoding clustered
microRNAs.
Stik G, Laurent S, Coupeau D, Coutaud B, Dambrine G, Rasschaert D, Muylkens B.
RNA. 2010 Nov;16(11):2263-76.
Hepatic microRNA expression is associated with the response to interferon treatment of chronic hepatitis C.
Murakami Y, Tanaka M, Toyoda H, Hayashi K, Kuroda M, Tajima A, Shimotohno K.
BMC Med Genomics. 2010 Oct 22;3:48.
Editing of Epstein-Barr virus-encoded BART6 microRNAs controls their dicer targeting and consequently affects viral latency.
Iizasa H, Wulff BE, Alla NR, Maragkakis M, Megraw M, Hatzigeorgiou A, Iwakiri D, Takada K, Wiedmer A, Showe L, Lieberman P,
Nishikura K.
J Biol Chem. 2010 Oct 22;285(43):33358-70.
Extra-cellular release and blood diffusion of BART viral micro-RNAs produced by EBV-infected nasopharyngeal carcinoma cells.
Gourzones C, Gelin A, Bombik I, Klibi J, Vérillaud B, Guigay J, Lang P, Témam S, Schneider V, Amiel C, Baconnais S, Jimenez AS,
Busson P.
Virol J. 2010 Oct 15;7:271.
Cytomegalovirus microRNAs facilitate persistent virus infection in salivary glands.
Dölken L, Krmpotic A, Kothe S, Tuddenham L, Tanguy M, Marcinowski L, Ruzsics Z, Elefant N, Altuvia Y, Margalit H, Koszinowski UH,
Jonjic S, Pfeffer S.
PLoS Pathog. 2010 Oct 14;6(10):e1001150.
Viruses, microRNAs, and host interactions.
Skalsky RL, Cullen BR.
Annu Rev Microbiol. 2010 Oct 13;64:123-41.
[MiR26a and miR939 regulate the replication of H1N1 influenza virus in MDCK cell].
Liu H, Song L, Huang W.
Wei Sheng Wu Xue Bao. 2010 Oct 4;50(10):1399-405.
Exploiting the therapeutic potential of microRNAs in viral diseases: expectations and limitations.
Hemida MG, Ye X, Thair S, Yang D.
Mol Diagn Ther. 2010 Oct 1;14(5):271-82.
Kaposi sarcoma (KS)-associated herpesvirus microRNA sequence analysis and KS risk in a European AIDS-KS case control study.
Marshall V, Martró E, Labo N, Ray A, Wang D, Mbisa G, Bagni RK, Volfovsky N, Casabona J, Whitby D; EURO-SHAKS Study Group.
J Infect Dis. 2010 Oct 1;202(7):1126-35.
Role of microRNAs in HTLV-1 infection and transformation.
Ruggero K, Corradin A, Zanovello P, Amadori A, Bronte V, Ciminale V, D'Agostino DM.
Mol Aspects Med. 2010 Oct;31(5):367-82.
Marek's disease virus-encoded microRNAs: genomics, expression and function.
Luo J, Teng M, Fan J, Wang F, Zhou L, Deng R, Zhang G.
Sci China Life Sci. 2010 Oct;53(10):1174-80.
miR-122 does not modulate the elongation phase of hepatitis C virus RNA synthesis in isolated replicase complexes.
Villanueva RA, Jangra RK, Yi M, Pyles R, Bourne N, Lemon SM.
Antiviral Res. 2010 Oct;88(1):119-23.
MicroRNA 203 expression in keratinocytes is dependent on regulation of p53 levels by E6.
McKenna DJ, McDade SS, Patel D, McCance DJ.
J Virol. 2010 Oct;84(20):10644-52.
MicroRNAs encoded by Kaposi's sarcoma-associated herpesvirus regulate viral life cycle.
Lu CC, Li Z, Chu CY, Feng J, Feng J, Sun R, Rana TM.
EMBO Rep. 2010 Oct;11(10):784-90.
A laboratory-attenuated vesicular stomatitis virus induces apoptosis and alters the cellular microRNA expression profile in BHK cells.
Lian H, Liu W, Liu Q, Jin H, Sun Y, Li J, Xia Z, Gao H.
Arch Virol. 2010 Oct;155(10):1643-53.
Identification of novel microRNA-like molecules generated from herpesvirus and host tRNA transcripts.
Reese TA, Xia J, Johnson LS, Zhou X, Zhang W, Virgin HW.
J Virol. 2010 Oct;84(19):10344-53.
Identification and analysis of expression of novel microRNAs of murine gammaherpesvirus 68.
Zhu JY, Strehle M, Frohn A, Kremmer E, Höfig KP, Meister G, Adler H.
J Virol. 2010 Oct;84(19):10266-75.
Cellular microRNAs 200b and 429 regulate the Epstein-Barr virus switch between latency and lytic replication.
Ellis-Connell AL, Iempridee T, Xu I, Mertz JE.
J Virol. 2010 Oct;84(19):10329-43.
Analysis of rhesus rhadinovirus microRNAs expressed in virus-induced tumors from infected rhesus macaques.
Umbach JL, Strelow LI, Wong SW, Cullen BR.
Virology. 2010 Sep 30;405(2):592-9.
Regulation of herpesvirus lifecycle by viral microRNAs.
Lei X, Bai Z, Ye F, Huang Y, Gao SJ.
Virulence. 2010 Sep-Oct;1(5):433-5.
Impact of microRNAs for pathogenesis and treatment of hepatitis C virus infection.
Pfeffer S, Baumert TF.
Gastroenterol Clin Biol. 2010 Sep;34(8-9):431-5.
Strong inverse correlation between microRNA-125b and human papillomavirus DNA in productive infection.
Nuovo GJ, Wu X, Volinia S, Yan F, di Leva G, Chin N, Nicol AF, Jiang J, Otterson G, Schmittgen TD, Croce C.
Diagn Mol Pathol. 2010 Sep;19(3):135-43.
Cellular microRNAs inhibit replication of the H1N1 influenza A virus in infected cells.
Song L, Liu H, Gao S, Jiang W, Huang W.
J Virol. 2010 Sep;84(17):8849-60.
Replication of subgenomic hepatitis C virus replicons in mouse fibroblasts is facilitated by deletion of interferon regulatory factor 3 and
expression of liver-specific microRNA 122.
Lin LT, Noyce RS, Pham TN, Wilson JA, Sisson GR, Michalak TI, Mossman KL, Richardson CD.
J Virol. 2010 Sep;84(18):9170-80.
The human cytomegalovirus microRNA miR-UL112 acts synergistically with a cellular microRNA to escape immune elimination.
Nachmani D, Lankry D, Wolf DG, Mandelboim O.
Nat Immunol. 2010 Sep;11(9):806-13.
Micro RNAs of Epstein-Barr virus promote cell cycle progression and prevent apoptosis of primary human B cells.
Seto E, Moosmann A, Grömminger S, Walz N, Grundhoff A, Hammerschmidt W.
PLoS Pathog. 2010 Aug 19;6(8). pii: e1001063.
tRNA Lys3 promoter cassettes that efficiently express RNAi-activating antihepatitis B virus short hairpin RNAs.
Dyer V, Ely A, Bloom K, Weinberg M, Arbuthnot P.
Biochem Biophys Res Commun. 2010 Aug 6;398(4):640-6.
miR-122-induced down-regulation of HO-1 negatively affects miR-122-mediated suppression of HBV.
Qiu L, Fan H, Jin W, Zhao B, Wang Y, Ju Y, Chen L, Chen Y, Duan Z, Meng S.
Biochem Biophys Res Commun. 2010 Aug 6;398(4):771-7.
Combined agonist-antagonist genome-wide functional screening identifies broadly active antiviral microRNAs.
Santhakumar D, Forster T, Laqtom NN, Fragkoudis R, Dickinson P, Abreu-Goodger C, Manakov SA, Choudhury NR, Griffiths SJ,
Vermeulen A, Enright AJ, Dutia B, Kohl A, Ghazal P, Buck AH.
Proc Natl Acad Sci U S A. 2010 Aug 3;107(31):13830-5.
Modulation of natural killer cell activity by viruses.
Lisnić VJ, Krmpotić A, Jonjić S.
Curr Opin Microbiol. 2010 Aug;13(4):530-9.
Viral miRNAs: tools for immune evasion.
Boss IW, Renne R.
Curr Opin Microbiol. 2010 Aug;13(4):540-5.
HIV-miR-H1 evolvability during HIV pathogenesis.
Lamers SL, Fogel GB, McGrath MS.
Biosystems. 2010 Aug;101(2):88-96.
Modulation of miR-122 on persistently Borna disease virus infected human oligodendroglial cells.
Qian J, Zhai A, Kao W, Li Y, Song W, Fu Y, Chen X, Zhang Q, Wu J, Li H, Zhong Z, Ling H, Zhang F.
Antiviral Res. 2010 Aug;87(2):249-56.
Small RNA profiling reveals antisense transcription throughout the KSHV genome and novel small RNAs.
Lin YT, Kincaid RP, Arasappan D, Dowd SE, Hunicke-Smith SP, Sullivan CS.
RNA. 2010 Aug;16(8):1540-58.
Differential expression of the miR-200 family microRNAs in epithelial and B cells and regulation of Epstein-Barr virus reactivation by the
miR-200 family member miR-429.
Lin Z, Wang X, Fewell C, Cameron J, Yin Q, Flemington EK.
J Virol. 2010 Aug;84(15):7892-7.
In vitro and in vivo characterization of microRNA-targeted alphavirus replicon and helper RNAs.
Kamrud KI, Coffield VM, Owens G, Goodman C, Alterson K, Custer M, Murphy MA, Lewis W, Timberlake S, Wansley EK, Berglund P,
Smith J.
J Virol. 2010 Aug;84(15):7713-25.
Lethal-7 is down-regulated by the hepatitis B virus x protein and targets signal transducer and activator of transcription 3.
Wang Y, Lu Y, Toh ST, Sung WK, Tan P, Chow P, Chung AY, Jooi LL, Lee CG.
J Hepatol. 2010 Jul;53(1):57-66.
CCL8/MCP-2 is a target for mir-146a in HIV-1-infected human microglial cells.
Rom S, Rom I, Passiatore G, Pacifici M, Radhakrishnan S, Del Valle L, Piña-Oviedo S, Khalili K, Eletto D, Peruzzi F.
FASEB J. 2010 Jul;24(7):2292-300.
DDX6 (Rck/p54) is required for efficient hepatitis C virus replication but not for internal ribosome entry site-directed translation.
Jangra RK, Yi M, Lemon SM.
J Virol. 2010 Jul;84(13):6810-24.
Regulation of hepatitis C virus translation and infectious virus production by the microRNA miR-122.
Jangra RK, Yi M, Lemon SM.
J Virol. 2010 Jul;84(13):6615-25.
MicroRNA miR-155 inhibits bone morphogenetic protein (BMP) signaling and BMP-mediated Epstein-Barr virus reactivation.
Yin Q, Wang X, Fewell C, Cameron J, Zhu H, Baddoo M, Lin Z, Flemington EK.
J Virol. 2010 Jul;84(13):6318-27.
A viral microRNA down-regulates multiple cell cycle genes through mRNA 5'UTRs.
Grey F, Tirabassi R, Meyers H, Wu G, McWeeney S, Hook L, Nelson JA.
PLoS Pathog. 2010 Jun 24;6(6):e1000967.
Influenza A virus-generated small RNAs regulate the switch from transcription to replication.
Perez JT, Varble A, Sachidanandam R, Zlatev I, Manoharan M, García-Sastre A, tenOever BR.
Proc Natl Acad Sci U S A. 2010 Jun 22;107(25):11525-30.
Engineered RNA viral synthesis of microRNAs.
Varble A, Chua MA, Perez JT, Manicassamy B, García-Sastre A, tenOever BR.
Proc Natl Acad Sci U S A. 2010 Jun 22;107(25):11519-24.
Down-regulation of a host microRNA by a Herpesvirus saimiri noncoding RNA.
Cazalla D, Yario T, Steitz J.
Science. 2010 Jun 18;328(5985):1563-6.
Utilizing liver-specific microRNA-122 to modulate replication of dengue virus replicon.
Lee TC, Lin YL, Liao JT, Su CM, Lin CC, Lin WP, Liao CL.
Biochem Biophys Res Commun. 2010 Jun 4;396(3):596-601.
Effect of ribavirin and interferon beta on miRNA profile in the hepatitis C virus subgenomic replicon-bearing Huh7 cells.
Gong BD, Xie Q, Xiang XG, Wang L, Zhao GD, An FM, Wang H, Lin LY, Yu H, Bao SS.
Int J Mol Med. 2010 Jun;25(6):853-9.
Gene bi-targeting by viral and human miRNAs.
Veksler-Lublinsky I, Shemer-Avni Y, Kedem K, Ziv-Ukelson M.
BMC Bioinformatics. 2010 May 13;11:249.
Moloney leukemia virus 10 (MOV10) protein inhibits retrovirus replication.
Wang X, Han Y, Dang Y, Fu W, Zhou T, Ptak RG, Zheng YH.
J Biol Chem. 2010 May 7;285(19):14346-55.
Reduced miR-34a expression in normal cervical tissues and cervical lesions with high-risk human papillomavirus infection.
Li B, Hu Y, Ye F, Li Y, Lv W, Xie X.
Int J Gynecol Cancer. 2010 May;20(4):597-604.
Effective inhibition of replication of infectious bursal disease virus by miRNAs delivered by vectors and targeting the VP2 gene.
Wang Y, Sun H, Shen P, Zhang X, Xia X, Xia B.
J Virol Methods. 2010 May;165(2):127-32.
Structural evaluation of new human polyomaviruses provides clues to pathobiology.
Johnson EM.
Trends Microbiol. 2010 May;18(5):215-23.
Cricket paralysis virus antagonizes Argonaute 2 to modulate antiviral defense in Drosophila.
Nayak A, Berry B, Tassetto M, Kunitomi M, Acevedo A, Deng C, Krutchinsky A, Gross J, Antoniewski C, Andino R.
Nat Struct Mol Biol. 2010 May;17(5):547-54.
MicroRNA-196 represses Bach1 protein and hepatitis C virus gene expression in human hepatoma cells expressing hepatitis C viral
proteins.
Hou W, Tian Q, Zheng J, Bonkovsky HL.
Hepatology. 2010 May;51(5):1494-504.
Numerous conserved and divergent microRNAs expressed by herpes simplex viruses 1 and 2.
Jurak I, Kramer MF, Mellor JC, van Lint AL, Roth FP, Knipe DM, Coen DM.
J Virol. 2010 May;84(9):4659-72.
A human herpesvirus microRNA inhibits p21 expression and attenuates p21-mediated cell cycle arrest.
Gottwein E, Cullen BR.
J Virol. 2010 May;84(10):5229-37.
Human papillomaviruses modulate expression of microRNA 203 upon epithelial differentiation to control levels of p63 proteins.
Melar-New M, Laimins LA.
J Virol. 2010 May;84(10):5212-21.
Comprehensive analysis of Rhesus lymphocryptovirus microRNA expression.
Riley KJ, Rabinowitz GS, Steitz JA.
J Virol. 2010 May;84(10):5148-57.
Viral envelope protein 53R gene highly specific silencing and iridovirus resistance in fish Cells by AmiRNA.
Kim YS, Ke F, Lei XY, Zhu R, Zhang QY.
PLoS One. 2010 Apr 23;5(4):e10308.
Analysis of microRNAs induced by Venezuelan equine encephalitis virus infection in mouse brain.
Bhomia M, Balakathiresan N, Sharma A, Gupta P, Biswas R, Maheshwari R.
Biochem Biophys Res Commun. 2010 Apr 23;395(1):11-6.
Systematic analysis of viral and cellular microRNA targets in cells latently infected with human gamma-herpesviruses by RISC
immunoprecipitation assay.
Dölken L, Malterer G, Erhard F, Kothe S, Friedel CC, Suffert G, Marcinowski L, Motsch N, Barth S, Beitzinger M, Lieber D, Bailer SM,
Hoffmann R, Ruzsics Z, Kremmer E, Pfeffer S, Zimmer R, Koszinowski UH, Grässer F, Meister G, Haas J.
Cell Host Microbe. 2010 Apr 22;7(4):324-34.
Functional delivery of viral miRNAs via exosomes.
Pegtel DM, Cosmopoulos K, Thorley-Lawson DA, van Eijndhoven MA, Hopmans ES, Lindenberg JL, de Gruijl TD, Würdinger T,
Middeldorp JM.
Proc Natl Acad Sci U S A. 2010 Apr 6;107(14):6328-33.
MicroRNAs control herpesviral dormancy.
Lei X, Bai Z, Ye F, Huang Y, Gao SJ.
Cell Cycle. 2010 Apr 1;9(7):1225-6.
Rational design of micro-RNA-like bifunctional siRNAs targeting HIV and the HIV coreceptor CCR5.
Ehsani A, Saetrom P, Zhang J, Alluin J, Li H, Snøve O Jr, Aagaard L, Rossi JJ.
Mol Ther. 2010 Apr;18(4):796-802.
Kaposi's sarcoma-associated herpesvirus-encoded viral FLICE inhibitory protein (vFLIP) K13 suppresses CXCR4 expression by
upregulating miR-146a.
Punj V, Matta H, Schamus S, Tamewitz A, Anyang B, Chaudhary PM.
Oncogene. 2010 Mar 25;29(12):1835-44.
MicroRNA antagonism of the picornaviral life cycle: alternative mechanisms of interference.
Kelly EJ, Hadac EM, Cullen BR, Russell SJ.
PLoS Pathog. 2010 Mar 19;6(3):e1000820.
Stimulation of inducible nitric oxide by hepatitis B virus transactivator protein HBx requires MTA1 coregulator.
Bui-Nguyen TM, Pakala SB, Sirigiri DR, Martin E, Murad F, Kumar R.
J Biol Chem. 2010 Mar 5;285(10):6980-6.
Epstein-Barr virus encoded LMP1 downregulates TCL1 oncogene through miR-29b.
Anastasiadou E, Boccellato F, Vincenti S, Rosato P, Bozzoni I, Frati L, Faggioni A, Presutti C, Trivedi P.
Oncogene. 2010 Mar 4;29(9):1316-28.
Systematic identification of microRNA and messenger RNA profiles in hepatitis C virus-infected human hepatoma cells.
Liu X, Wang T, Wakita T, Yang W.
Virology. 2010 Mar 1;398(1):57-67.
Epigenetic regulation of latent HSV-1 gene expression.
Bloom DC, Giordani NV, Kwiatkowski DL.
Biochim Biophys Acta. 2010 Mar-Apr;1799(3-4):246-56.
Hepatitis C virus' Achilles' heel--dependence on liver-specific microRNA miR-122.
Norman KL, Sarnow P.
Cell Res. 2010 Mar;20(3):247-9.
Epigenetic regulation of Kaposi's sarcoma-associated herpesvirus latency by virus-encoded microRNAs that target Rta and the cellular
Rbl2-DNMT pathway.
Lu F, Stedman W, Yousef M, Renne R, Lieberman PM.
J Virol. 2010 Mar;84(6):2697-706.
MicroRNA expression and virulence in pandemic influenza virus-infected mice.
Li Y, Chan EY, Li J, Ni C, Peng X, Rosenzweig E, Tumpey TM, Katze MG.
J Virol. 2010 Mar;84(6):3023-32.
Five questions about viruses and microRNAs.
Cullen BR.
PLoS Pathog. 2010 Feb 26;6(2):e1000787.
Six RNA viruses and forty-one hosts: viral small RNAs and modulation of small RNA repertoires in vertebrate and invertebrate systems.
Parameswaran P, Sklan E, Wilkins C, Burgon T, Samuel MA, Lu R, Ansel KM, Heissmeyer V, Einav S, Jackson W, Doukas T, Paranjape
S, Polacek C, dos Santos FB, Jalili R, Babrzadeh F, Gharizadeh B, Grimm D, Kay M, Koike S, Sarnow P, Ronaghi M, Ding SW, Harris E,
Chow M, Diamond MS, Kirkegaard K, Glenn JS, Fire AZ.
PLoS Pathog. 2010 Feb 12;6(2):e1000764.
Contribution of genome-wide HCV genetic differences to outcome of interferon-based therapy in Caucasian American and African
American patients.
Donlin MJ, Cannon NA, Aurora R, Li J, Wahed AS, Di Bisceglie AM, Tavis JE; Virahep-C Study Group.
PLoS One. 2010 Feb 3;5(2):e9032.
A novel qPCR assay for viral encoded microRNAs.
Reichenstein I, Aizenberg N, Goshen M, Bentwich Z, Avni YS.
J Virol Methods. 2010 Feb;163(2):323-8.
Attenuation of vesicular stomatitis virus encephalitis through microRNA targeting.
Kelly EJ, Nace R, Barber GN, Russell SJ.
J Virol. 2010 Feb;84(3):1550-62.
Post-transcriptional regulation of miR-27 in murine cytomegalovirus infection.
Buck AH, Perot J, Chisholm MA, Kumar DS, Tuddenham L, Cognat V, Marcinowski L, Dölken L, Pfeffer S.
RNA. 2010 Feb;16(2):307-15.
Regulation of NF-kappaB inhibitor IkappaBalpha and viral replication by a KSHV microRNA.
Lei X, Bai Z, Ye F, Xie J, Kim CG, Huang Y, Gao SJ.
Nat Cell Biol. 2010 Feb;12(2):193-9.
Upregulation of xCT by KSHV-encoded microRNAs facilitates KSHV dissemination and persistence in an environment of oxidative stress.
Qin Z, Freitas E, Sullivan R, Mohan S, Bacelieri R, Branch D, Romano M, Kearney P, Oates J, Plaisance K, Renne R, Kaleeba J, Parsons
C.
PLoS Pathog. 2010 Jan 29;6(1):e1000742.
Targeting viral infection by microRNA inhibition.
Roberts AP, Jopling CL.
Genome Biol. 2010 Jan 26;11(1):201.
A mammalian herpesvirus uses noncanonical expression and processing mechanisms to generate viral MicroRNAs.
Bogerd HP, Karnowski HW, Cai X, Shin J, Pohlers M, Cullen BR.
Mol Cell. 2010 Jan 15;37(1):135-42.
KSHV-encoded miRNAs target MAF to induce endothelial cell reprogramming.
Hansen A, Henderson S, Lagos D, Nikitenko L, Coulter E, Roberts S, Gratrix F, Plaisance K, Renne R, Bower M, Kellam P, Boshoff C.
Genes Dev. 2010 Jan 15;24(2):195-205.
Adenovirus VA RNA-derived miRNAs target cellular genes involved in cell growth, gene expression and DNA repair.
Aparicio O, Carnero E, Abad X, Razquin N, Guruceaga E, Segura V, Fortes P.
Nucleic Acids Res. 2010 Jan 1;38(3):750-63.
[Construction and in vitro antiviral activity of highly effective artificial miRNA targeting to HIV-1 pol].
Cheng T, Zhang T, Zhang Y, Wei L, Xia D, Wang Y, Zhang J, Xia N.
Sheng Wu Gong Cheng Xue Bao. 2010 Jan;26(1):63-73.
[Construction of highly effective artifical miRNA targeted to HIV-1 vif and the lentiviral-mediated antiviral research in vitro]
Zhang T, Cheng T, Wei LH, Zhang YL, Wang YB, Cai YJ, Zhang J, Xia NS.
Bing Du Xue Bao. 2010 Jan;26(1):8-15.
[Research advances on anti-apoptosis effect of herpes simplex virus latency-associated transcripts]
Yang HL, Bai LL, Fan JY.
Bing Du Xue Bao. 2010 Jan;26(1):76-9.
A lentiviral vector encoding two fluorescent proteins enables imaging of adenoviral infection via adenovirus-encoded miRNAs in single
living cells.
Kato Y, Sawata SY, Inoue A.
J Biochem. 2010 Jan;147(1):63-71.
Discriminating mutations of HC-Pro of zucchini yellow mosaic virus with differential effects on small RNA pathways involved in viral
pathogenicity and symptom development.
Wu HW, Lin SS, Chen KC, Yeh SD, Chua NH.
Mol Plant Microbe Interact. 2010 Jan;23(1):17-28.
Mature and functional viral miRNAs transcribed from novel RNA polymerase III promoters.
Diebel KW, Smith AL, van Dyk LF.
RNA. 2010 Jan;16(1):170-85.
Editorial: quality versus quantity in myeloid infection by a herpesvirus: more than one way to skin the CCAAT?
Lukac DM.
J Leukoc Biol. 2010 Jan;87(1):9-12.
Pivotal advance: Kaposi's sarcoma-associated herpesvirus (KSHV)-encoded microRNA specifically induce IL-6 and IL-10 secretion by
macrophages and monocytes.
Qin Z, Kearney P, Plaisance K, Parsons CH.
J Leukoc Biol. 2010 Jan;87(1):25-34.
Characterization of microRNAs encoded by the bovine herpesvirus 1 genome.
Glazov EA, Horwood PF, Assavalapsakul W, Kongsuwan K, Mitchell RW, Mitter N, Mahony TJ.
J Gen Virol. 2010 Jan;91(Pt 1):32-41.
Functional analysis of a cellular microRNA in insect host-ascovirus interaction.
Hussain M, Asgari S.
J Virol. 2010 Jan;84(1):612-20.
Modulation of hepatitis C virus RNA abundance and the isoprenoid biosynthesis pathway by microRNA miR-122 involves distinct
mechanisms.
Norman KL, Sarnow P.
J Virol. 2010 Jan;84(1):666-70.
A global analysis of evolutionary conservation among known and predicted gammaherpesvirus microRNAs.
Walz N, Christalla T, Tessmer U, Grundhoff A.
J Virol. 2010 Jan;84(2):716-28.
Identification of viral microRNAs expressed in human sacral ganglia latently infected with herpes simplex virus 2.
Umbach JL, Wang K, Tang S, Krause PR, Mont EK, Cohen JI, Cullen BR.
J Virol. 2010 Jan;84(2):1189-92.
Herpes simplex virus type 1 (HSV-1)-induced apoptosis in human dendritic cells as a result of downregulation of cellular FLICE-inhibitory
protein and reduced expression of HSV-1 antiapoptotic latency-associated transcript sequences.
Kather A, Raftery MJ, Devi-Rao G, Lippmann J, Giese T, Sandri-Goldin RM, Schönrich G.
J Virol. 2010 Jan;84(2):1034-46.
Down-regulation of a host microRNA by a viral noncoding RNA.
Cazalla D, Steitz JA.
Cold Spring Harb Symp Quant Biol. 2010;75:321-4.
Identification and validation of the cellular targets of virus-encoded microRNAs.
Kok KH, Lei T, Jin DY.
Methods Mol Biol. 2010;667:319-26.
Identification of microRNAs involved in the host response to enterovirus 71 infection by a deep sequencing approach.
Cui L, Guo X, Qi Y, Qi X, Ge Y, Shi Z, Wu T, Shan J, Shan Y, Zhu Z, Wang H.
J Biomed Biotechnol. 2010;2010:425939.
High-throughput sequencing of microRNAs in adenovirus type 3 infected human laryngeal epithelial cells.
Qi Y, Tu J, Cui L, Guo X, Shi Z, Li S, Shi W, Shan Y, Ge Y, Shan J, Wang H, Lu Z.
J Biomed Biotechnol. 2010;2010:915980.
Monosodium luminol upregulates the expression of Bcl-2 and VEGF in retrovirus-infected mice through downregulation of corresponding
miRNAs.
Lungu G, Kuang X, Stoica G, Wong PK.
Acta Virol. 2010;54(1):27-32.
Expression of microRNA-155 precursor in peripheral blood mononuclear cells from Hepatitis C patients after antiviral treatment.
Sidorkiewicz M, Grek M, Jozwiak B, Majda-Stanislawska E, Piekarska A, Bartkowiak J.
Acta Virol. 2010;54(1):75-8.
Current knowledge of MicroRNAs and noncoding RNAs in virus-infected cells.
Ouellet DL, Provost P.
Methods Mol Biol. 2010;623:35-65.